Member Info for philg65

Couple of 1M sells already.

Must admit, this does present us with an excellent buying opportunity, both for trading and LTH.

Same old spike and retrace with this share. One day Rodders........!!!

Don't expect any significant revenue figures just yet. The only projections we have are what was stated in the Fundraising circular, and these are only internal targets by the company: Having assessed potential prospects in the bioprocessing and traditional small molecule markets, the Directors have set internal targets for 2022 of sales of approximately 390 to 450 MS instruments and revenues of between £17 million to £19 million. The Directors have estimated that approximately 70 per cent. would come from the bioprocessing market in 2022 and the balance would come from the Company's traditional small molecule market. The targeted revenues include recurring revenue in the form of consumables and service fee income.

Surely we have to see some uplift here soon. Becoming a little frustrating.

Another Disti deal, this time in the UK. Great news but no doubt the SP will be a temporary blip! Let's see if this will kick start it!

We see a load of buys streaming through today and the price hardly budges. Looks like the MMs are keeping a lid on this, either to fill a larger buy or..........

Maybe I'm a sucker for punishment, but I've just topped up at these unbelievable pricing levels. The MM's are up to their usual tricks in showing them as sells. We could certainly do with an injection of something into this SP.........

Knew he would sell out. He reckons that he's still holding but probably significantly reduced his holding here. Onwards and upwards

Alot of those sells are actual buys. MM's again love to hood wink us!

A tad disappointing that the SP drops to this level but it is so obvious that things are progressing very positively with the big biopharma. Not too sure that we will touch my projected figures of double digits for the SP, by year end but then again.........surprise me!!

What a pathetic post. They have secured extra funding and even the directors have dipped a chunk in.

Interesting part:- Having assessed potential prospects in the bioprocessing and traditional small molecule markets, the Directors have set internal targets for 2022 of sales of approximately 390 to 450 MS instruments and revenues of between GBP17 million to GBP19 million. The Directors have estimated that approximately 70 per cent. would come from the bioprocessing market in 2022 and the balance would come from the Company's traditional small molecule market. The targeted revenues include recurring revenue in the form of consumables and service fee income. The above numbers are the Company's internal targets only and are not forecasts. Longer term, potential sales opportunities The Directors believe that the Company has a number of longer-term potential sales opportunities. These include the following: -- the use of the Company's compact point of need MS technology across multiple entry points in the bioprocessing workflow; -- potential use in other biologic-related markets requiring on-line process monitoring, such as cell therapies; -- potential use of compact MS as a method for point of care diagnostics; and -- potential collaboration on the next generation of compact MS leveraging the Company's proof of concept "triple quad" technology.

So you obviously sold out then as on Thursday you intimated about bring on the 9's.........lol

Seller still there.....yawn!

Nice that you've placed me in the subject header....:)) Mozax, don't get me wrong, the distribution agreements are the best way forward and of course I'm holding tight to realise its true value. Frustratingly, alot of other stocks will have shot up on this type of news but I just wish the seller FO. These agreements also take time for integration of MSYS product range and then months down the line, can we truly know the commercial position/success.

Excuse me for not getting too excited as the SP will probably spike and then over the course of the next week or so, fall back to the usual trading range. As for the agreement, it just gets better and better. The management have their finger on the pulse. Maybe the seller has dried up and a rerate is now on the cards!!!!!!!!.

If the MMs want to hold it here then they will certainly try. The volume needs to pick up here.

If we get additional announcements including the big one as well as the seller disappearing down a plughole, then I'll pitch at 12.8p.

Zoo, I've already topped up today. We just need the seller to FO and let the beast be unleashed!!! Shall we start a what price the SP will be by end of the Sept 18?